S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Enzo Biochem (ENZ) Earnings Date, Estimates & Call Transcripts

$1.09
-0.04 (-3.54%)
(As of 04/19/2024 08:50 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

ENZ Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENZ Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ENZ Earnings Date and Information

Enzo Biochem has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 12th, 2024 based off prior year's report dates.

Enzo Biochem Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/12/2024
Estimated)
------- 
12/15/2023Q1 2024-($0.11)($0.11)($0.09)-$7.81 million
6/14/2023Q3 2023-($0.31)($0.31)($0.31)-$16.11 million
3/20/2023Q2 2023-($0.23)($0.23)($0.23)-$16.34 million
12/12/2022Q1 2023-($0.18)($0.18)($0.14)-$18.28 million    
10/14/2022Q4 2022-($0.17)($0.17)($0.17)-$20.28 million
6/9/2022Q3 2022-($0.09)($0.09)($0.08)-$26.22 million
3/14/2022Q2 2022-$0.03+$0.03$0.11-$34.05 million    
12/15/2021Q1 2022-($0.04)($0.04)($0.03)-$26.52 million
10/12/2021Q4 2021-$0.07+$0.07$0.07-$24.81 million
6/9/2021Q3 2021-$0.04+$0.04$0.04-$32.80 million

Enzo Biochem Earnings - Frequently Asked Questions

When is Enzo Biochem's earnings date?

Enzo Biochem has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 12th, 2024 based off last year's report dates. Learn more on ENZ's earnings history.

How much revenue does Enzo Biochem generate each year?

Enzo Biochem (NYSE:ENZ) has a recorded annual revenue of $31.06 million.

How much profit does Enzo Biochem generate each year?

Enzo Biochem (NYSE:ENZ) has a recorded net income of $20.29 million. ENZ has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NYSE:ENZ) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners